Clinical Trial
doi: 10.1002/ana.410130616.
Tetrahydrocannabinol for tremor in multiple sclerosis
- PMID: 6309074
- DOI: 10.1002/ana.410130616
Item in Clipboard
Clinical Trial
Tetrahydrocannabinol for tremor in multiple sclerosis
Ann Neurol.
1983 Jun.
Abstract
Based on one patient's enthusiastic report, eight patients with multiple sclerosis, seriously disabled with tremor and ataxia, were given oral tetrahydrocannabinol. Two demonstrated improved motor coordination.
Similar articles
-
[Attempts at pharmacological and surgical treatment of intentional and postural tremor in patients with disseminated sclerosis (authors transl)].Przegl Lek. 1976;33(9):796-800. Przegl Lek. 1976. PMID: 796900 Polish. No abstract available.
-
The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.Mult Scler. 2009 Mar;15(3):371-8. doi: 10.1177/1352458508099142. Epub 2009 Jan 23. Mult Scler. 2009. PMID: 19168602 Clinical Trial.
-
Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.Clin Ther. 2007 Sep;29(9):2068-79. doi: 10.1016/j.clinthera.2007.09.013. Clin Ther. 2007. PMID: 18035205 Clinical Trial.
-
[Symptomatic treatment of multiple sclerosis].Rev Neurol. 2002 Dec 16-31;35(12):1141-53. Rev Neurol. 2002. PMID: 12497297 Review. Spanish.
-
Dronabinol in tremor.Ann Pharmacother. 1993 Nov;27(11):1357-8. Ann Pharmacother. 1993. PMID: 8286811 Review. No abstract available.
Cited by
-
Cannabinoid-Based Medicines and Multiple Sclerosis.Adv Exp Med Biol. 2021;1264:111-129. doi: 10.1007/978-3-030-57369-0_8. Adv Exp Med Biol. 2021. PMID: 33332007 Review.
-
Pharmacokinetics and pharmacodynamics of cannabinoids.Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003. Clin Pharmacokinet. 2003. PMID: 12648025 Review.
-
Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.Br J Pharmacol. 2016 Nov;173(22):3196-3207. doi: 10.1111/bph.13581. Epub 2016 Oct 4. Br J Pharmacol. 2016. PMID: 27545646 Free PMC article.
-
[The endogenous cannabinoid system. Therapeutic implications for neurologic and psychiatric disorders].Nervenarzt. 2005 Sep;76(9):1062, 1065-6, 1068-72 passim. doi: 10.1007/s00115-005-1888-7. Nervenarzt. 2005. PMID: 15776259 Review. German.
-
[Therapeutic use of cannabinoids in neurology].Schmerz. 2003 Oct;17(5):367-73. doi: 10.1007/s00482-003-0240-z. Schmerz. 2003. PMID: 14513344 Review. German.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
